Vietnam tests chat and text to boost flu shots for seniors
NCT ID NCT07508189
First seen Jun 25, 2026 · Last updated Jul 07, 2026 · Updated 4 times
Summary
This study tests whether a community-based communication program can increase flu vaccination rates among people over 65 in Can Tho City, Vietnam. The program includes direct counseling, weekly health tips via the Zalo app, and printed leaflets. Researchers will compare vaccination rates between groups that get the program and those that don't over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Multi-component Health Communication Package (counseling, Zalo messages, leaflets)
- What this could lead to
- If it works, this could show a simple way to get more elderly people vaccinated against the flu, reducing illness and hospital visits.
- What could go wrong
- This is a behavioral study, not a medical treatment. Success depends on people actually getting the vaccine, and results may not apply outside Vietnam.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH COMMUNICATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Can Tho University of Medicine and Pharmacy
Can Tho, Can Tho City, 900000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New mRNA vaccine aims to outsmart flu by targeting its hidden parts
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
- One shot to beat the flu? new drug peramivir tested in large trial
- Can a One-Page guide spark better End-of-Life talks for dementia patients?
- Doctor training aims to boost vaccine rates